Expression of A D isintegrin a nd M etalloprotease (ADAM) enzymes in human squamous cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 704s Year: 2004
Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020
A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Metalloproteinase-9 and tissue inhibitor of metalloproteinase in baker‘s asthma Source: Eur Respir J 2005; 26: Suppl. 49, 603s Year: 2005
ADAMS (A Disintegrins and Metalloproteinases) in the pathogenesis of asthma Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis Year: 2013
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 92s Year: 2002
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011
Matrix metalloproteinase -9 and neutrophil elastase complexed with α 1 - inhibitor proteinase in children with recurrent upper respiratory tract diseases Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001
The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002
Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013
Activity of matrix metalloproteinases and their inhibitor in children with bronchopulmonary dysplasia Source: Annual Congress 2009 - Respiratory physiology in infants and preschool children, in health and disease Year: 2009
Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung Source: International Congress 2016 – Molecular immunology of the lung Year: 2016
Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Matrix metalloproteinase (MMP ) -1 and -3 promoter polymorphisms in Bulgarian patients with COPD Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Matrix metalloproteinase 2 expression in distal lung of fatal asthma Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006